# Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers

> **NCT03837093** · PHASE1 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ILT101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03837093
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-06
- **Primary completion:** 2021-03-03
- **Final completion:** 2021-11-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03837093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03837093, "Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03837093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*